Header Logo

Connection

THOMAS WHEELER to Mass Screening

Back to Details
This is a "connection" page, showing publications THOMAS WHEELER has written about Mass Screening.
THOMAS WHEELER
Connection Strength
0.004
Mass Screening
  1. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. J Cell Biochem Suppl. 1994; 19:283-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.